このページの翻訳は実験的なもので、現在開発中です。お待ちしております！
Dolby Laboratories バランスシートの健全性
財務の健全性 基準チェック /66
Dolby Laboratoriesの総株主資本は$2.4B 、総負債は$0.0で、負債比率は0%となります。総資産と総負債はそれぞれ$3.0Bと$607.0Mです。 Dolby Laboratoriesの EBIT は$238.5Mで、利息カバレッジ比率-7です。現金および短期投資は$825.4Mです。
主要情報
0%
負債資本比率
US$0
負債
| インタレスト・カバレッジ・レシオ | -7x |
| 現金 | US$825.40m |
| エクイティ | US$2.44b |
| 負債合計 | US$607.04m |
| 総資産 | US$3.04b |
財務の健全性に関する最新情報
更新なし
Recent updates
Dolby Laboratories: A Sound Player, Trading At A Too-Rich Valuation
Jun 10Should You Think About Buying Dolby Laboratories, Inc. (NYSE:DLB) Now?
Jun 07
Dolby Laboratories Remains A Hold
May 14Dolby Laboratories, Inc. (NYSE:DLB) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
May 05Dolby Laboratories, Inc.'s (NYSE:DLB) Earnings Haven't Escaped The Attention Of Investors
May 02Investors Will Want Dolby Laboratories' (NYSE:DLB) Growth In ROCE To Persist
Apr 16Dolby Laboratories, Inc. (NYSE:DLB) Shares Could Be 26% Below Their Intrinsic Value Estimate
Mar 17Dolby Laboratories Sees Flat Revenue Ahead (Downgrade)
Mar 01Dolby Laboratories' (NYSE:DLB) Earnings Offer More Than Meets The Eye
Feb 09What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jan 31With Dolby Laboratories, Inc. (NYSE:DLB) It Looks Like You'll Get What You Pay For
Jan 15The Return Trends At Dolby Laboratories (NYSE:DLB) Look Promising
Dec 28Dolby Laboratories: On A Positive Hold As Shareholder Rewards Continue
Dec 06A Look At The Fair Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Nov 18At US$81.66, Is Dolby Laboratories, Inc. (NYSE:DLB) Worth Looking At Closely?
Oct 11Dolby Laboratories: High P/E Is Not Justified, A Hold For Now
Sep 13The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing
Aug 03What Is Dolby Laboratories, Inc.'s (NYSE:DLB) Share Price Doing?
Jul 12Dolby Laboratories Sees Return To Growth Ahead
Jun 22Returns On Capital At Dolby Laboratories (NYSE:DLB) Paint A Concerning Picture
May 04A Look At The Intrinsic Value Of Dolby Laboratories, Inc. (NYSE:DLB)
Apr 14Is There Now An Opportunity In Dolby Laboratories, Inc. (NYSE:DLB)?
Mar 29Dolby Laboratories goes ex-dividend on Monday
Feb 10Dolby Laboratories FQ1 2023 Earnings Preview
Feb 01Dolby Laboratories (NYSE:DLB) Could Be At Risk Of Shrinking As A Company
Jan 24Dolby: A 2023 Update, And Still A 'Hold'
Jan 11An Intrinsic Calculation For Dolby Laboratories, Inc. (NYSE:DLB) Suggests It's 25% Undervalued
Jan 09Is Dolby Laboratories, Inc. (NYSE:DLB) Potentially Undervalued?
Dec 25Dolby Laboratories' (NYSE:DLB) Dividend Will Be Increased To $0.27
Nov 21Dolby: Great Moat But Not Such A Great Investment Idea
Oct 29Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 38% Undervaluation?
Oct 05Dolby Laboratories Seeks Broader Growth As Macro Conditions Weigh
Sep 28財務状況分析
短期負債: DLBの 短期資産 ( $1.6B ) が 短期負債 ( $442.9M ) を超えています。
長期負債: DLBの短期資産 ( $1.6B ) が 長期負債 ( $164.1M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: DLBは負債がありません。
負債の削減: DLB過去 5 年間負債を抱えていません。
債務返済能力: DLBには負債がないため、営業キャッシュフロー でカバーする必要はありません。
インタレストカバレッジ: DLBには負債がないため、利息支払い の負担は問題になりません。